Recent Findings Confirm LIM Domain Kinases as Emerging Target Candidates for Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|12|5|543-560

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.12, Iss.5, 2012-05, pp. : 543-560

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Receptor Tyrosine Kinases as Target for Anti-Cancer Therapy

By  

Current Pharmaceutical Design, Vol. 8, Iss. 22, 2002-10 ,pp. : 1959-1972

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: Protein Kinases in Cancer: Recent Findings (Guest Editor: Silvia Schenone)]

By  

Current Medicinal Chemistry, Vol. 18, Iss. 19, 2011-06 ,pp. : 2826-2826

Bentham Science Publishers

Access to resources Recommend Favorite

Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 9, Iss. 8, 2009-12 ,pp. : 938-952

Bentham Science Publishers

Access to resources Recommend Favorite

Lipoxygenase: An Emerging Target for Stroke Therapy

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 2, 2013-04 ,pp. : 191-199

Bentham Science Publishers

Access to resources Recommend Favorite

Proteasome as an Emerging Therapeutic Target in Cancer

By  

Current Pharmaceutical Design, Vol. 13, Iss. 5, 2007-02 ,pp. : 471-485

Bentham Science Publishers

Access to resources Recommend Favorite